Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“Wow, a Mayo Clinic study reported today at SNO2025 showing exactly what we have been saying about ALC. In patients with brain tumors of all types, when ALC falls below 750 cells, survival is significantly shorter at only 3.7 months vs 7.7 months (P=0.0063). Finally the light is shining that NK cells matter.”
More posts featuring Patrick Soon-Shiong on OncoDaily.